Through our relentless dedication, we have emerged as frontrunners in the fields of oncology, hematology, transplant cases, and rare diseases. Since 2004, we have proudly partnered with over 15 international companies and extended our reach to several other Latin American nations.
Our primary focus is on developing and manufacturing high-quality pharmaceuticals, driven by an unwavering commitment to optimizing patient care. Our distinguished reputation stems from long-standing collaborations with the medical and scientific communities, where we prioritize innovation and continuous improvement in line with rigorous international quality standards.
registered
products worldwide
products in
Latin America
24th Lymphoma, Leukemia, and Myeloma Congress: the ideal scenario to reaffirm our commitment.
Leading the pharmaceutical industry into the future.
We had the pleasure of attending the Hematology Update Conference on October 1st.
A record-breaking congress with the latest innovations.
A different approach to managing symptoms associated with uterine fibroids.
Connecting with the medical community at the 61st Argentine Congress of Urology, hosted by the SAU.
As part of the Interior Conferences organized by the Hematology Society.
We launched Ledaga®, the first gel for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma approved in Argentina.
Both the medical community and Varifarma have reason to celebrate! Our product has been added to two of the leading medical recommendation guidelines.
Another year of expanding our scientific expertise in this academic event.
In Varifarma we continue to take part in scientific events to stay at the forefront of new healthcare innovations.
Find the latest news of this innovative test as a genomic tool to evaluate tumour behavior over the years for an accurate choice of treatment.
Setting a new standard of care in advanced prostate cancer treatment.
At Varifarma, we had the opportunity to actively participate in the congress, where we attended scientific sessions, workshops, and meetings with leading experts in the field.
Supporting Hospital Durand's inaugural Blue Run to fight prostate cancer.
